FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204759452> ?p ?o ?g. }

• W3204759452 endingPage "1181" @default.
• W3204759452 startingPage "1167" @default.
• W3204759452 abstract "The rapid development of immune checkpoint blockade (ICB) therapies has revolutionized the cancer treatment landscape and brightened the long-term forecast for many cancer patients. However, the specific genomic and proteomic changes in tumors treated with different ICB treatments have yet to be fully characterized. We treated four non-small-cell lung carcinoma (NSCLC) tumor digests ex vivo with the anti-PD-L1 antibody durvalumab (D) alone or in combination with the anti-CTLA-4 antibody tremelimumab (T) to explore changes in gene and protein expression associated with these ICB therapies. All four tumors showed a robust increase in interferon gamma (IFN-γ) production (100-300% higher than isotype control) in both D- and D + T-treated tumors. Three of the four tumors showed additional increases in IFN-γ production with D + T compared with D (40-70%). A substantial reduction in interleukin 10 (IL-10) was also found in three of the four tumors (reduced to 4-8%) in response to D and D + T. Conventional CD4 + /CD8 + populations and T cell activation markers increased after D and D + T treatment. D and D + T upregulated multiple IPA pathways involving T cell activation. D + T resulted in additional upregulation of Th1/Th2 pathways through a different set of genes, as well as greater reduction in genes involved in epithelial-mesenchymal transition (EMT), angiogenesis, and cancer stemness. Our results demonstrated that D + T augmented the effects of D in the microenvironment of this set of NSCLC tumors. The specific impact of D + T on the regulation of EMT, angiogenesis, and cancer stemness warrants further evaluation in a larger set of tumors." @default.
• W3204759452 created "2021-10-11" @default.
• W3204759452 creator A5011470254 @default.
• W3204759452 creator A5034269049 @default.
• W3204759452 creator A5036760632 @default.
• W3204759452 creator A5064617600 @default.
• W3204759452 creator A5072180051 @default.
• W3204759452 creator A5082831559 @default.
• W3204759452 creator A5086078883 @default.
• W3204759452 date "2021-10-08" @default.
• W3204759452 modified "2023-09-27" @default.
• W3204759452 title "Effects of combination treatment with durvalumab plus tremelimumab on the tumor microenvironment in non-small-cell lung carcinoma" @default.
• W3204759452 cites W1974259787 @default.
• W3204759452 cites W2025459290 @default.
• W3204759452 cites W2036012609 @default.
• W3204759452 cites W2126747224 @default.
• W3204759452 cites W2141072599 @default.
• W3204759452 cites W2152928287 @default.
• W3204759452 cites W2155926280 @default.
• W3204759452 cites W2307487014 @default.
• W3204759452 cites W2620804290 @default.
• W3204759452 cites W2793633504 @default.
• W3204759452 cites W2801309958 @default.
• W3204759452 cites W2807947863 @default.
• W3204759452 cites W2883694743 @default.
• W3204759452 cites W2884091495 @default.
• W3204759452 cites W2887577080 @default.
• W3204759452 cites W2895417117 @default.
• W3204759452 cites W2945436660 @default.
• W3204759452 cites W2953836551 @default.
• W3204759452 cites W2965334126 @default.
• W3204759452 cites W2986438911 @default.
• W3204759452 cites W3031070321 @default.
• W3204759452 cites W4255724971 @default.
• W3204759452 doi "https://doi.org/10.1007/s00262-021-03065-5" @default.
• W3204759452 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34623465" @default.
• W3204759452 hasPublicationYear "2021" @default.
• W3204759452 type Work @default.
• W3204759452 sameAs 3204759452 @default.
• W3204759452 citedByCount "4" @default.
• W3204759452 countsByYear W32047594522022 @default.
• W3204759452 countsByYear W32047594522023 @default.
• W3204759452 crossrefType "journal-article" @default.
• W3204759452 hasAuthorship W3204759452A5011470254 @default.
• W3204759452 hasAuthorship W3204759452A5034269049 @default.
• W3204759452 hasAuthorship W3204759452A5036760632 @default.
• W3204759452 hasAuthorship W3204759452A5064617600 @default.
• W3204759452 hasAuthorship W3204759452A5072180051 @default.
• W3204759452 hasAuthorship W3204759452A5082831559 @default.
• W3204759452 hasAuthorship W3204759452A5086078883 @default.
• W3204759452 hasBestOaLocation W32047594521 @default.
• W3204759452 hasConcept C104317684 @default.
• W3204759452 hasConcept C121608353 @default.
• W3204759452 hasConcept C126322002 @default.
• W3204759452 hasConcept C127561419 @default.
• W3204759452 hasConcept C143998085 @default.
• W3204759452 hasConcept C167672396 @default.
• W3204759452 hasConcept C203014093 @default.
• W3204759452 hasConcept C2776090121 @default.
• W3204759452 hasConcept C2776107976 @default.
• W3204759452 hasConcept C2776256026 @default.
• W3204759452 hasConcept C2777367678 @default.
• W3204759452 hasConcept C2777701055 @default.
• W3204759452 hasConcept C2777742743 @default.
• W3204759452 hasConcept C2778650287 @default.
• W3204759452 hasConcept C2779013556 @default.
• W3204759452 hasConcept C2780030458 @default.
• W3204759452 hasConcept C2780394083 @default.
• W3204759452 hasConcept C2780851360 @default.
• W3204759452 hasConcept C2781433595 @default.
• W3204759452 hasConcept C502942594 @default.
• W3204759452 hasConcept C55493867 @default.
• W3204759452 hasConcept C71924100 @default.
• W3204759452 hasConcept C76419328 @default.
• W3204759452 hasConcept C86803240 @default.
• W3204759452 hasConcept C8891405 @default.
• W3204759452 hasConceptScore W3204759452C104317684 @default.
• W3204759452 hasConceptScore W3204759452C121608353 @default.
• W3204759452 hasConceptScore W3204759452C126322002 @default.
• W3204759452 hasConceptScore W3204759452C127561419 @default.
• W3204759452 hasConceptScore W3204759452C143998085 @default.
• W3204759452 hasConceptScore W3204759452C167672396 @default.
• W3204759452 hasConceptScore W3204759452C203014093 @default.
• W3204759452 hasConceptScore W3204759452C2776090121 @default.
• W3204759452 hasConceptScore W3204759452C2776107976 @default.
• W3204759452 hasConceptScore W3204759452C2776256026 @default.
• W3204759452 hasConceptScore W3204759452C2777367678 @default.
• W3204759452 hasConceptScore W3204759452C2777701055 @default.
• W3204759452 hasConceptScore W3204759452C2777742743 @default.
• W3204759452 hasConceptScore W3204759452C2778650287 @default.
• W3204759452 hasConceptScore W3204759452C2779013556 @default.
• W3204759452 hasConceptScore W3204759452C2780030458 @default.
• W3204759452 hasConceptScore W3204759452C2780394083 @default.
• W3204759452 hasConceptScore W3204759452C2780851360 @default.
• W3204759452 hasConceptScore W3204759452C2781433595 @default.
• W3204759452 hasConceptScore W3204759452C502942594 @default.
• W3204759452 hasConceptScore W3204759452C55493867 @default.
• W3204759452 hasConceptScore W3204759452C71924100 @default.

• next